Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Aneta Kacprzak (Warsaw, Poland), Aneta Kacprzak, Monika Szturmowicz, Monika Franczuk, Barbara Burakowska, Marcin Kurzyna, Anna Fijalkowska, Agnieszka Skoczylas, Stefan Wesolowski, Jan Kus, Adam Torbicki. Clinical meaning of low DLCO in idiopathic pulmonary arterial hypertension (IPAH) - Prospective single centre study. Eur Respir J 2015; 46: Suppl. 59, 2117

Member's Comments

No comment yet.

Related content which might interest you: Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension Source: International Congress 2014 – Comorbidities Year: 2014 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH) Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Contrasting physiological responses to the six minute walk test in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (IPAH) Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Pulmonary function is associated with pulmonary artery systolic pressure in the general population: The Rotterdam study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced COPD Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Characteristics of idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (APAH-CTD) patients in PROSPECT Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Investigation of balance deficits in patients with pulmonary arterial hypertension: Preliminary study Source: International Congress 2015 – Physiotherapy assessment and techniques in pulmonary and non-pulmonary conditions Year: 2015 Characteristics of a stable and satisfactory condition in long term survivors of pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Muscle function and physical activity in patients with idiopathic pulmonary arterial hypertension (IPAH) Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Effects of pulmonary rehabilitation (PR) in idiopathic pulmonary arterial hypertension (PAHI) Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013 Pulmonary arterial hypertension patients underrepresented in clinical trials – Are they different? Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015